GlassScriptPhysician profile
Nancy K Bridgens
NPI 1689720963
$623.00
in general payments reported to CMS, 2019-2025
10 companies · $27.72 in 2025
The $27.72 reported for 2025 was less than what a typical Maternal & Fetal Medicine provider received nationally (typical 2025 total: $55.21).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.25 · 2020: $23.74 · 2021: $117 · 2022: $195 · 2023: $249 · 2025: $27.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $276.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $212.65 | 2022-2023 | |
| Abbvie INC. | $161.70 | 2021-2023 | Liletta |
| Sumitomo Pharma America, INC. | $85.37 | 2023-2025 | Myfembree, Gemtesa |
| Hologic Sales and Service, LLC | $54.29 | 2020-2023 | Aptima, Thinprep 2000 Processor |
| Organon LLC | $21.53 | 2022 | |
| Ardelyx, INC. | $21.03 | 2023 | Ibsrela |
| Caldera Medical, INC | $20.88 | 2023 | Desara |
| Exeltis, USA INC. | $17.97 | 2022 | |
| Janssen Biotech, INC. | $16.33 | 2023 | Simponi, Simponi Aria, Remicade |
| Amag Pharmaceuticals, INC. | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Bridgens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.